Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoon-Kyo An

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Gastroenterology and Hepatology|April 5, 2021
Common mistakes with steroidsYoon-Kyo An
BMJ Case Reports|December 14, 2022
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosisReuben Malloy, Richard Fernandes, Jakob Begun, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 8, 2026
Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging TherapeuticsYoon-Kyo An, Robert Gilmore, Graham Radford-Smith, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Comprehensive systematic review and pooled analysis of real-world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatmentEmi Khoo, Andrew Lee, Teresa Neeman, et al.
Journal of Crohn'S & Colitis|July 9, 2023
Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative ColitisRobert Gilmore, Wei Lian Tan, Richard Fernandes, et al.
Intestinal Research|June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's diseaseRobert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
The Medical Journal of Australia|November 5, 2019
Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysisYoon-Kyo An, David Prince, Fergus Gardiner, et al.
The Medical Journal of Australia|October 18, 2020
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort studyCraig Haifer, Ashish Srinivasan, Yoon-Kyo An, et al.
Journal of Gastroenterology and Hepatology|July 28, 2025
Point-of-Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional InvestigationsWei-Lian Tan, Emi Khoo, Myat-Myat Khaing, et al.
Journal of Crohn'S & Colitis|December 2, 2025
Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfactionRichard G Fernandes, Emi Khoo, Heidi Jensen Harris, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Gastroenterology and Hepatology|April 5, 2021
Common mistakes with steroidsYoon-Kyo An
BMJ Case Reports|December 14, 2022
Refractory fulminant colitis following ocrelizumab therapy requiring colectomy in a patient with multiple sclerosisReuben Malloy, Richard Fernandes, Jakob Begun, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|April 8, 2026
Advances in Crohn's Disease: A Comprehensive Review of Pathophysiology, Diagnosis, and Emerging TherapeuticsYoon-Kyo An, Robert Gilmore, Graham Radford-Smith, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
Comprehensive systematic review and pooled analysis of real-world studies evaluating immunomodulator and biologic therapies for chronic pouchitis treatmentEmi Khoo, Andrew Lee, Teresa Neeman, et al.
Journal of Crohn'S & Colitis|July 9, 2023
Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative ColitisRobert Gilmore, Wei Lian Tan, Richard Fernandes, et al.
Intestinal Research|June 9, 2025
Upadacitinib and vedolizumab combination therapy for the management of refractory ulcerative colitis and Crohn's diseaseRobert Gilmore, Amrutha Murali, Amirah Etchegaray, et al.
The Medical Journal of Australia|November 5, 2019
Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysisYoon-Kyo An, David Prince, Fergus Gardiner, et al.
The Medical Journal of Australia|October 18, 2020
Switching Australian patients with moderate to severe inflammatory bowel disease from originator to biosimilar infliximab: a multicentre, parallel cohort studyCraig Haifer, Ashish Srinivasan, Yoon-Kyo An, et al.
Journal of Gastroenterology and Hepatology|July 28, 2025
Point-of-Care Intestinal Ultrasound Impacts Inflammatory Bowel Disease Care and Reduces the Need for Additional InvestigationsWei-Lian Tan, Emi Khoo, Myat-Myat Khaing, et al.
Journal of Crohn'S & Colitis|December 2, 2025
Cost-effective inflammatory bowel disease flare pathway with nurse-led triage and rapid access intestinal ultrasound reduces hospital resource use with high patient satisfactionRichard G Fernandes, Emi Khoo, Heidi Jensen Harris, et al.
Pageof 3